KRYS (STOCKS)
Krystal Biotech, Inc. Common Stock
$272.650000
+1.950000 (+0.72%)
Prev close: $270.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Krish S. Krishnan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,896.60M
- Employees
- 275
- P/E (TTM)
- 40.60
- P/B (TTM)
- 6.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$2.66 | $1.11 | +1.5527 | +140.22% |
|
Jun 2025 (Q2)
|
$1.29 | $1.15 | +0.1397 | +12.14% |
|
Mar 2025 (Q1)
|
$1.20 | $1.39 | -0.1936 | -13.89% |
|
Dec 2024 (Q4)
|
$1.52 | $1.19 | +0.3295 | +27.68% |
Financial Statements
| Assets | $1.24B |
| Current Assets | $925.65M |
| Cash | $731.10M |
| Inventory | $37.63M |
| Other Current Assets | $156.92M |
| Noncurrent Assets | $314.44M |
| Fixed Assets | $148.87M |
| Other Non-current Assets | $165.57M |
| Liabilities | $102.22M |
| Current Liabilities | $91.27M |
| Accounts Payable | $2.10M |
| Other Current Liabilities | $89.17M |
| Noncurrent Liabilities | $10.95M |
| Equity | $1.14B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.14B |
| Liabilities And Equity | $1.24B |